Cargando…

Is more involvement needed in the clinical trial design & endpoints?

Detalles Bibliográficos
Autor principal: Vroom, Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504544/
http://dx.doi.org/10.1186/1750-1172-7-S2-A38
_version_ 1782250651818917888
author Vroom, Elizabeth
author_facet Vroom, Elizabeth
author_sort Vroom, Elizabeth
collection PubMed
description
format Online
Article
Text
id pubmed-3504544
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35045442012-11-27 Is more involvement needed in the clinical trial design & endpoints? Vroom, Elizabeth Orphanet J Rare Dis Meeting Abstract BioMed Central 2012-11-22 /pmc/articles/PMC3504544/ http://dx.doi.org/10.1186/1750-1172-7-S2-A38 Text en Copyright ©2012 Vroom; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Meeting Abstract
Vroom, Elizabeth
Is more involvement needed in the clinical trial design & endpoints?
title Is more involvement needed in the clinical trial design & endpoints?
title_full Is more involvement needed in the clinical trial design & endpoints?
title_fullStr Is more involvement needed in the clinical trial design & endpoints?
title_full_unstemmed Is more involvement needed in the clinical trial design & endpoints?
title_short Is more involvement needed in the clinical trial design & endpoints?
title_sort is more involvement needed in the clinical trial design & endpoints?
topic Meeting Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504544/
http://dx.doi.org/10.1186/1750-1172-7-S2-A38
work_keys_str_mv AT vroomelizabeth ismoreinvolvementneededintheclinicaltrialdesignendpoints